Pharma and business groups welcome commitments laid out in official statements on future UK-EU relationship
Industry groups have welcomed the proposed approaches to negotiations over the future relationship between the EU and the UK after Brexit.
In a statement issued on 3 February, prime minister Boris Johnson said that “annexes to the agreement could include provisions facilitating trade in specific sectors”, including pharmaceuticals.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.